Svb Wealth LLC Pfizer Inc Transaction History

Svb Wealth LLC

$117 Million
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$25.26 - $29.6 $644,761 - $755,540	-25,525 Reduced 4.29%	569,574 $15.9 Million
Q1 2024 May 15, 2024	BUY	$25.89 - $29.73 $324,634 - $372,784	12,539 Added 2.15%	595,099 $16.5 Million
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $933,546 - $1.21 Million	-35,727 Reduced 5.78%	582,560 $16.8 Million
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $790,312 - $923,796	-24,628 Reduced 3.83%	618,287 $20.5 Million
Q2 2023 Jul 24, 2023	BUY	$36.12 - $41.79 $7.64 Million - $8.84 Million	211,450 Added 49.01%	642,915 $23.6 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $1.46 Million - $1.91 Million	-37,165 Reduced 7.93%	431,465 $17.6 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $53,732 - $70,141	-1,287 Reduced 0.27%	468,630 $24 Million
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $1 Million - $1.23 Million	22,935 Added 5.13%	469,917 $20.6 Million
Q2 2022 Aug 16, 2022	BUY	$46.53 - $55.17 $107,577 - $127,553	2,312 Added 0.52%	446,982 $23.4 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $355,386 - $440,367	7,768 Added 1.78%	444,670 $23 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $168,379 - $249,593	-4,075 Reduced 0.92%	436,902 $25.8 Million
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $231,928 - $297,931	-5,909 Reduced 1.32%	440,977 $19 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $265,446 - $300,706	-7,392 Reduced 1.63%	446,886 $17.5 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $548,934 - $619,088	-16,391 Reduced 3.48%	454,278 $16.5 Million
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $80,963 - $102,952	-2,419 Reduced 0.51%	470,669 $17.3 Million
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $96,805 - $113,575	-3,049 Reduced 0.64%	473,088 $17.4 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $23,373 - $28,355	776 Added 0.16%	476,137 $15.6 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $1.58 Million - $2.26 Million	-58,437 Reduced 10.95%	475,361 $15.5 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $273,005 - $309,826	-8,293 Reduced 1.53%	533,798 $20.9 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $3.49 Million - $4.53 Million	-107,472 Reduced 16.55%	542,091 $19.5 Million
Q2 2019 Jul 10, 2019	SELL	$36.98 - $41.52 $8.44 Million - $9.48 Million	-228,271 Reduced 26.0%	649,563 $28.1 Million
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $1.05 Million - $1.16 Million	-28,132 Reduced 3.11%	877,834 $37.3 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $268,751 - $306,405	-6,986 Reduced 0.77%	905,966 $39.5 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $122,368 - $148,425	-3,550 Reduced 0.39%	912,952 $40.2 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $1.12 Million - $1.19 Million	-33,979 Reduced 3.57%	916,502 $33.3 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $506,220 - $587,285	-15,864 Reduced 1.64%	950,481 $33.7 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $452,336 - $479,944	-13,600 Reduced 1.39%	966,345 $35 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $30.4 Million - $33.5 Million	979,945	979,945 $35 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.6 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.2 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.66 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.32 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.43 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Account